Strategies for ADC Bioanalysis: Building for Complexity, Designing for the Future
Resolian’s Andy Xue on what makes ADC bioanalysis uniquely demanding, and how the team builds scalable, drug-tolerant methods across ADCs, PDCs, and AOCs.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
